FAQ

home FAQ

FQA

Treatment with FACILLE family series typically takes less than one hour (individual treatment time may vary).
Consult your healthcare professionals about your expected pain control before treatment.
The healthcare professionals should disinfect the treated area before treatment.
To achieve the best FACILLE performance, the healthcare professional would use appropriate needles for injection.

Primary component of dermal filler is Hyaluronic acid. It is a carbohydrate occurring naturally throughout the human and animal body. It keeps tissue hydration and makes plump of the skin, but decreases with aging. It also acts as a humectant which locks in moisture, rejuvenates and restores plumpness of the skin. Dermal Filler contains stabilized Hyaluronic acid which is highly biocompatible and identical in all living organisms. Dermal Fillers serves as a medium for plumping up skin concavity, reducing Hyaluronic Acid degradation and supplementing elasticity of skin for a period of time. It gives skin flexibility and helps you appear younger. It is recommended to assemble adequate needles for ensuring the safety with FACILLE series of products.

Any injection may cause personal discomfort. Techniques for injecting FACILLE series of products may differ from different experienced and trained professionals. Applying topical anesthesia to the injected area before treatment can reduce patients’ intraoperative pain as much as possible.

The implantation of the product must be practiced under national legislation by authorized professionals, trained with implantation injection and have sufficient anatomical knowledge of treatment site. Injecting Dermal Fillers with anesthetics into human body operated by qualified professionals is regarded as a safe procedure. However, any injection procedure is associated with risks of infection. Experienced and trained authorized professionals with appropriate injecting techniques may reduce risk of inflammation. Also, please consult professionals to evaluate your physical condition (e.g. potential side effects/symptoms, any allergies, medication…) and actively inform doctors of these information.

  • There are some contraindications for the use of FACILLE family series of products in those who:

  • Have hypersensitivity to hyaluronic acid

  • Have hypersensitivity to lidocaine or amide-type local anaesthetics

  • Have untreated epilepsy or suffer from porphyria or methemoglobinemia

  • Have coagulation disorders or impaired platelet functions or receive those which cause anticoagulant effect, for example, concurrent treatment with non-steroidal anti-inflammatory drugs, aspirin, anticoagulants, thrombolytics, angiotonics, ginseng, ginkgo or garlic extract, and so on.

  • Common injection-related adverse events might be experienced after treatment including: erythema, swelling, pain, pruritus, haphalgesia, tenderness, contusion, bruising, haemorrhage and suppuration. These reactions would be resolved within 1 to 2 weeks without any intended treatments.

  • Other side effects have been reported post-marketing for the products are nodules, discoloration, skin eruption, desquamation, pigmentation changes, lip blister, granuloma, numbness, allergies, irregular shape (papules/depressed deformation) or foreign body sensation.
    The above responses are likely to last more than two weeks, or even delay to appear until after several weeks.

  • No severe adverse events have been recognized as FACILLE series of products or device-related.

  • Normally, tissue infections and skin necrosis may not be resolved easily. Its causes are related to professionals’ operation and injection errors rather than dermal fillers and device-related.

  • If any side-effect occurs, must be reported to your healthcare professionals, and get medical care immediately.

  • Periodic touch-up can help sustain the desired appealing corrections.

Consulting your healthcare professionals if you have history of allergy to hyaluronic acid or any other compounds. The injection will not be arranged until the safety of human-body responses to products has been confirmed.

Any implantation may let you have foreign body sensation, but it will gradually disappear within several weeks.

  • KEEP injection site dry and clean after treatment within at least 2 weeks.

  • AVOID touching implant area, taking alcohol, drugs, or applying facial care products and cosmetics few days after injection to decline stronger bruising, swelling, and the risk of inflammation.

  • AVOID exposing injection sites to hot and humid environment, such as solarium, sauna and sunlight or frigid climate environment until initial swelling and redness have recovered.

  • AVOID injecting complementary gels in implant areas after treatment in the next 7 days.

  • DO NOT over massage or compress the fragile implant area few days after injection for reducing risk of wound contamination or irregular shape.

  • AVOID excessive movements, such as jumping, jogging and running, to decrease risk of local mobility and implant displacement.